Chongqing Zhouqing Yuankang Glass Co., Ltd. is located at No. 11 Hefeng Avenue, Fuling District, Chongqing. Its predecessor was the "Chongqing Fuling District No.15 Middle School Bottle Factory" established in 1995. It is a collective enterprise specializing in the production of various types of glass tube oral liquid bottles for pharmaceutical packaging materials, specifically providing glass tube bottles for Taiji Group Fuling Pharmaceutical Factory. In 2009, the "Bottle Factory of No.15 Middle School in Fuling District, Chongqing" was renamed as "Chongqing Yuankang Pharmaceutical Packaging Materials Co., Ltd. In November 2018, Zhejiang Zhouqing Pharmaceutical Packaging Co., Ltd. acquired a controlling stake in the company through capital increase (holding 51% of the shares). At the same time, the company name was changed to "Chongqing Zhouqing Yuankang Glass Co., Ltd.

In 2019, Yuankang Pharmaceutical Glass acquired 50 mu of land in Fuling New Area Industrial Park and invested in building an integrated base for R&D, production, and sales. The project introduced intelligent production equipment such as automatic tube loaders, automatic bottle sorters, automatic inspection machines, and automatic heat-shrink packaging machines, and systematically upgraded the existing production processes. Upon full commissioning, the annual production capacity of pharmaceutical glass bottles will reach 3 billion pieces. The project has now started construction, and the first phase was completed and put into operation in December 2022.

The company currently has two "Drug Packaging Materials and Container Registration Certificates (Class I)" issued by the State Food and Drug Administration, with a building area of over 14000 square meters, 15 bottle production lines, and more than 80 employees (including 10 technical and R&D personnel). It can produce 800 million glass controlled bottles annually. The product has been exported to provinces and cities such as Chongqing, Sichuan, Hunan, Jiangxi, Fujian, and Xinjiang.

For a long time, the company has continuously increased investment in enterprise digitalization, information management, new product R&D, and intelligent equipment upgrading, with R&D expenses totaling over 3.2 million yuan in 2024. Up to now, it has obtained 3 invention patents, 25 utility model patents, and 1 design patent. In 2019, it was recognized as a "National High-tech Enterprise" and passed the re-examination in 2022. In 2023, it was identified as a "Chongqing Specialized, Special and New Enterprise".

Yuankang will always uphold the corporate spirit of "Innovation, Exploration, Competition, and Struggle", strictly adhere to product quality with a pursuit of excellence, and is committed to providing more professional and high-quality pharmaceutical packaging services for pharmaceutical enterprises nationwide.